Mirati Therapeutics, Inc. - 60468T105
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Description is not available for this instrument yet.
Quarter snapshot
Latest / Compare
Q1 2024
· Q4 2023
Value (USD)
Total reported value ($000)
$44.61M
QoQ value delta ($000)
-$2.842B
(-98.45%)
Implied price effect (QoQ)
-0.02%
Shares
Total shares
759,316
QoQ shares delta
-48,372,974
(-98.45%)
Total shares held by funds (by quarter)
Top holders (Q1 2024)
Top 25 only
Full list
Partial Q1 2024 data: 1 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| NORGES BANK | 44,156 | 751,604 | 0.01% |
| D. E. Shaw & Co., Inc. | 451 | 7,693 | 0.0% |
| IFP Advisors, Inc | 1 | 19 | 0.0% |